RHJ Begent

705 total citations
18 papers, 564 citations indexed

About

RHJ Begent is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, RHJ Begent has authored 18 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in RHJ Begent's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Glycosylation and Glycoproteins Research (3 papers). RHJ Begent is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Glycosylation and Glycoproteins Research (3 papers). RHJ Begent collaborates with scholars based in United Kingdom and United States. RHJ Begent's co-authors include R Boden, RB Pedley, R.G. Dale, F Searle, JA Ledermann, Damian Marshall, K. D. Bagshawe, K D Bagshawe, RG Melton and DJ King and has published in prestigious journals such as British Journal of Cancer.

In The Last Decade

RHJ Begent

18 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RHJ Begent United Kingdom 14 377 233 131 51 48 18 564
Melissa Nelson United States 11 208 0.6× 185 0.8× 197 1.5× 55 1.1× 24 0.5× 21 516
Partha Mukhopadhyay India 13 58 0.2× 337 1.4× 171 1.3× 107 2.1× 74 1.5× 41 618
Zeyu Xiao China 17 176 0.5× 198 0.8× 83 0.6× 141 2.8× 51 1.1× 46 826
S. Mohammadtaghi United Kingdom 6 143 0.4× 166 0.7× 115 0.9× 37 0.7× 46 1.0× 8 596
Michael E. Ottlinger United States 8 83 0.2× 189 0.8× 104 0.8× 46 0.9× 63 1.3× 10 675
James A. Lofgren United States 9 263 0.7× 433 1.9× 182 1.4× 193 3.8× 24 0.5× 12 674
G. Vierwinden Netherlands 11 100 0.3× 117 0.5× 52 0.4× 115 2.3× 16 0.3× 14 390
Blanca L. Valle United States 8 163 0.4× 169 0.7× 92 0.7× 29 0.6× 34 0.7× 12 437
Umbreen Hafeez Australia 7 184 0.5× 163 0.7× 252 1.9× 83 1.6× 16 0.3× 14 463
Gerrard J. Perdok Netherlands 9 271 0.7× 239 1.0× 33 0.3× 93 1.8× 23 0.5× 11 558

Countries citing papers authored by RHJ Begent

Since Specialization
Citations

This map shows the geographic impact of RHJ Begent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RHJ Begent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RHJ Begent more than expected).

Fields of papers citing papers by RHJ Begent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RHJ Begent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RHJ Begent. The network helps show where RHJ Begent may publish in the future.

Co-authorship network of co-authors of RHJ Begent

This figure shows the co-authorship network connecting the top 25 collaborators of RHJ Begent. A scholar is included among the top collaborators of RHJ Begent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RHJ Begent. RHJ Begent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
King, DJ, et al.. (1998). Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle. British Journal of Cancer. 78(10). 1307–1312. 4 indexed citations
2.
3.
Delgado, Cristina, RB Pedley, Ángel Herráez, et al.. (1996). Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification. British Journal of Cancer. 73(2). 175–182. 53 indexed citations
4.
King, DJ, et al.. (1996). Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments. British Journal of Cancer. 74(9). 1397–1405. 44 indexed citations
5.
Marshall, Damian, et al.. (1995). Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody. British Journal of Cancer. 71(1). 18–24. 31 indexed citations
6.
Marshall, Damian, et al.. (1994). Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. British Journal of Cancer. 69(3). 502–507. 25 indexed citations
7.
Pedley, RB, et al.. (1994). Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA) – implications for targeted therapy. British Journal of Cancer. 69(2). 307–314. 12 indexed citations
8.
Pedley, RB, et al.. (1994). The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody. British Journal of Cancer. 70(6). 1126–1130. 46 indexed citations
9.
Boden, R, et al.. (1993). Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model. British Journal of Cancer. 68(1). 69–73. 53 indexed citations
10.
Boultbee, J. E., et al.. (1992). Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy. British Journal of Cancer. 66(5). 883–887. 23 indexed citations
11.
Hennigan, Tom, RHJ Begent, & T G Allen-Mersh. (1991). Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model. British Journal of Cancer. 64(5). 872–874. 20 indexed citations
12.
Newlands, ES, et al.. (1990). Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. British Journal of Cancer. 61(2). 323–324. 38 indexed citations
13.
Begent, RHJ, et al.. (1990). Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry. British Journal of Cancer. 61(2). 218–220. 9 indexed citations
14.
Begent, RHJ, JA Ledermann, K D Bagshawe, et al.. (1989). Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. British Journal of Cancer. 60(3). 406–412. 50 indexed citations
15.
Crawford, S. M., et al.. (1989). The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy. British Journal of Cancer. 59(2). 243–246. 9 indexed citations
16.
Ledermann, JA, et al.. (1988). Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. British Journal of Cancer. 58(5). 654–657. 65 indexed citations
17.
Ledermann, JA, RHJ Begent, & K. D. Bagshawe. (1988). Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits. British Journal of Cancer. 58(5). 562–566. 17 indexed citations
18.
Begent, RHJ, et al.. (1987). The clinical value of imaging with antibody to human chorionic gonadotrophin in the detection of residual choriocarcinoma. British Journal of Cancer. 55(6). 657–660. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Nelson Breakdown of academic impact, for papers by Partha Mukhopadhyay Breakdown of academic impact, for papers by Zeyu Xiao Breakdown of academic impact, for papers by S. Mohammadtaghi Breakdown of academic impact, for papers by Michael E. Ottlinger Breakdown of academic impact, for papers by James A. Lofgren Breakdown of academic impact, for papers by G. Vierwinden Breakdown of academic impact, for papers by Blanca L. Valle Breakdown of academic impact, for papers by Umbreen Hafeez Breakdown of academic impact, for papers by Gerrard J. Perdok
Rankless by CCL
2026